A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But beyond this, their regained weight plateaus, with individu ...

A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.

A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But beyond this, their regained weight plateaus, with individuals managing ...

A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain, on average, 60% of their lost ...

Despite this, researchers have cautioned that if the regained weight is predominantly fat, people could "be worse off than ...

Popular GLP-1 receptor agonist drugs for weight loss, also known as GLP-1 RAs, appear to be similarly effective among ...

A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain on average 60% of their lost weight – but beyond this, their ...

Researchers say around half the weight lost during treatment is usually muscle and if the regained mass is mainly fat, patients' long-term health may be better if they had not taken the drugs at all.

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows. Semaglutide (also known as Ozempic) ...

People on obesity jabs such as Mounjaro or Wegovy will regain almost two thirds of the weight they lose within a year of stopping the drugs, a study suggests. However, the period of piling on the ...

People on obesity jabs such as Mounjaro or Wegovy will regain almost two thirds of the weight they lose within a year of ...

A Cambridge University study found people who stop taking weight loss jabs such as Mounjaro and Wegovy regain almost two-thirds of the weight they lost ...